Editorial Comment to Utility of robot‐assisted radical cystectomy with intracorporeal urinary diversion for muscle‐invasive bladder cancer

Abstract

ing robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur. Urol. 2015; 68: 721–8. 12 Wilson TG, Guru K, Rosen RC et al. Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. Eur. Urol. 2015; 67: 423–31. 13 Koie T, Ohyama C, Yoneyama T et al. Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: initial experience and functional outcomes. Int. J. Med. Robot. 2018; 23: e1955. 14 Simone G, Papalia R, Misuraca L et al. Robotic intracorporeal padua ileal bladder: surgical technique, perioperative, oncologic and functional outcomes. Eur. Urol. 2018; 73: 934–40. 15 Minervini A, Vanacore D, Vittori G et al. Florence robotic intracorporeal neobladder (FloRIN): a new reconfiguration strategy developed following the IDEAL guidelines. BJU Int. 2018; 121: 313–7. 16 Hussein AA, Ahmed YE, Kozlowski JD et al. Robot-assisted approach to “W”-configuration urinary diversion: a step-by-step technique. BJU Int. 2017; 120: 152–7. 17 Chopra S, de Castro Abreu AL, Berger AK et al. Evolution of robot-assisted orthotopic ileal neobladder formation: a step-by-step update to the University of Southern California (USC) technique. BJU Int. 2017; 119: 185–91. 18 Tan WS, Sridhar A, Goldstraw M et al. Robot-assisted intracorporeal pyramid neobladder.. BJU Int. 2015; 116: 771–9. 19 Zakaria AS, Santos F, Dragomir A et al. Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: a populationbased analysis during the years 2000-2009. Can. Urol. Assoc. J. 2014; 8: 259–67. 20 Guru KA, Kim HL, Piacente PM et al. Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute. Urology 2007; 69: 469–74. 21 Gandaglia G, Karl A, Novara G et al. Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: a comparison of two high-volume referral centers. Eur. J. Surg. Oncol. 2016; 42: 1736–43. 22 Li K, Lin T, Fan X et al. Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy. Cancer Treat. Rev. 2013; 39: 551–60. 23 Al-Daghmin A, Aboumohamed A, Din R et al. Readmission after robotassisted radical cystectomy: outcomes and predictors at 90-day follow-up. Urology 2014; 83: 350–6. 24 Yuh B, Wilson T, Bochner B et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur. Urol. 2015; 67: 402–22. 25 Guyen DP, Al Awamlh BAH, Wu X et al. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur. Urol. 2015; 68: 399–405. 26 Parekh DJ, Reis IM, Castle EP et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 2018; 391: 2525–36. 27 Witjes JA, Comp erat E, Cowan NC et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur. Urol. 2014; 65: 778–92. 28 The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Bladder Cancer. [Cited 23 Jun 2016.] Available from URL: http:// www.nccn.org/professionals/physician_gls/PDF/bladder.pdf 29 Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 2003; 349: 859–66. 30 International Collaboration of Trial on behalf of the Medical Research Council Advanced Bladder Cancer Working Party. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J. Clin. Oncol. 2011; 29: 2171–7. 31 Koie T, Ohyama C, Yamamoto H et al. Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer. Med. Oncol. 2014; 31: 949. 32 Koie T, Ohyama C, Hashimoto Y et al. Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study. Int. J. Clin. Oncol. 2013; 18: 724–30. 33 Murasawa H, Koie T, Ohyama C et al. The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy. Int. J. Clin. Oncol. 2017; 22: 159–65. 34 Hinata N, Hussein A, George S et al. Impact of suboptimal neoadjuvant chemotherapy on perioperative outcomes and survival after robot-assisted radical cystectomy: a multicenter multinational study. BJU Int. 2017; 119: 605–11. 35 Patel HR, Santos PB, de Oliveira MC et al. Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care? World J. Urol. 2016; 34: 25–32. 36 Iwamoto H, Yumioka T, Yamaguchi N et al. Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians. Int. J. Clin. Oncol. 2016; 21: 756–63. 37 Ahmed K, Khan SA, Hayn MH et al. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur. Urol. 2014; 65: 340–7. 38 Lenfant L, Verhoest G, Campi R et al. Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study. World J. Urol. 2018; https://doi.org/10.1007/s00345-018-2313-8. 39 Tyritzis SI, Hosseini A, Collins J et al. Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion. Eur. Urol. 2013; 64: 734–41. 40 Simone G, Tuderti G, Misuraca L et al. Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: results of a propensity score matched comparison with open cohort from a single-centre series. Eur. J. Surg. Oncol. 2018; 44: 1432–8. 41 Tan TW, Nair R, Saad S et al. Safe transition from extracorporeal to intracorporeal urinary diversion following robot-assisted cystectomy: a recipe for reducing operative time, blood loss and complication rates. World J. Urol. 2018; https://doi.org/10.1007/s00345-018-2386-4. 42 Butt ZA, Forbes E, Zorn J et al. Robotic radical cystectomy with intracorporeal neobladder: initial experience and outcomes. Can. Urol. Assoc. J. 2015; 9: E156–9. 43 Schwentner C, Sim A, Balbay MD et al. Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure. World J. Surg. Oncol. 2015; 13: 3. 44 Desai MM, Gill IS, de Castro Abreu AL et al. Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients. J. Urol. 2014; 192: 1734–40.